Medicover AB (publ)
MCVEY · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $2 | $2 | $2 | $1 |
| % Growth | 19.8% | 15.6% | 9.6% | – |
| Cost of Goods Sold | $2 | $1 | $1 | $1 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 21.4% | 20.6% | 22.2% | 28.7% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $0 | $0 | $0 | $0 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Income | $0 | $0 | $0 | $0 |
| % Margin | 3.4% | 3.5% | 3.7% | 11.6% |
| Other Income/Exp. Net | -$0 | -$0 | -$0 | -$0 |
| Pre-Tax Income | $0 | $0 | $0 | $0 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | $0 | $0 | $0 | $0 |
| % Margin | 0.8% | 1% | 0.8% | 7.4% |
| EPS | 0.11 | 0.12 | 0.079 | 0.69 |
| % Growth | -8.3% | 51.9% | -88.6% | – |
| EPS Diluted | 0.11 | 0.12 | 0.079 | 0.69 |
| Weighted Avg Shares Out | 0 | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 0 | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | $0 | $0 | $0 | $0 |
| % Margin | 13.2% | 14.8% | 14.3% | 20% |